JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2013, Volume 61, Issue 14, pp. 1489 - 1495
Objectives This study sought to describe the natural history of combined stenotic and regurgitant aortic valve disease. Background Data on outcome and...
Cardiovascular | Internal Medicine | aortic valve | aortic regurgitation | aortic stenosis | natural history | CARDIAC & CARDIOVASCULAR SYSTEMS | STENOSIS | VALVULAR HEART-DISEASE | FOLLOW-UP | INTERVENTIONS | TASK-FORCE | RECOMMENDATIONS | PREDICTORS | CLINICAL-PRACTICE | ASSOCIATION | DOPPLER-ECHOCARDIOGRAPHY | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Male | Postoperative Complications - mortality | Aortic Valve Stenosis - diagnostic imaging | Austria | Aortic Valve Stenosis - epidemiology | Prosthesis Failure | Time Factors | Echocardiography, Doppler | Adult | Female | Aortic Valve Stenosis - surgery | Severity of Illness Index | Aortic Valve Insufficiency - diagnostic imaging | Postoperative Complications - physiopathology | Risk Assessment | Comorbidity | Heart Valve Prosthesis | Kaplan-Meier Estimate | Proportional Hazards Models | Heart Valve Prosthesis Implantation - methods | Heart Valve Prosthesis Implantation - mortality | Survival Rate | Treatment Outcome | Disease-Free Survival | Aortic Valve Insufficiency - surgery | Aged | Aortic Valve Insufficiency - epidemiology | Cohort Studies | Medical colleges | Heart valve diseases | Cardiology | Cardiovascular disease | Heart attacks | Coronary vessels
Cardiovascular | Internal Medicine | aortic valve | aortic regurgitation | aortic stenosis | natural history | CARDIAC & CARDIOVASCULAR SYSTEMS | STENOSIS | VALVULAR HEART-DISEASE | FOLLOW-UP | INTERVENTIONS | TASK-FORCE | RECOMMENDATIONS | PREDICTORS | CLINICAL-PRACTICE | ASSOCIATION | DOPPLER-ECHOCARDIOGRAPHY | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Male | Postoperative Complications - mortality | Aortic Valve Stenosis - diagnostic imaging | Austria | Aortic Valve Stenosis - epidemiology | Prosthesis Failure | Time Factors | Echocardiography, Doppler | Adult | Female | Aortic Valve Stenosis - surgery | Severity of Illness Index | Aortic Valve Insufficiency - diagnostic imaging | Postoperative Complications - physiopathology | Risk Assessment | Comorbidity | Heart Valve Prosthesis | Kaplan-Meier Estimate | Proportional Hazards Models | Heart Valve Prosthesis Implantation - methods | Heart Valve Prosthesis Implantation - mortality | Survival Rate | Treatment Outcome | Disease-Free Survival | Aortic Valve Insufficiency - surgery | Aged | Aortic Valve Insufficiency - epidemiology | Cohort Studies | Medical colleges | Heart valve diseases | Cardiology | Cardiovascular disease | Heart attacks | Coronary vessels
Journal Article
JACC: Cardiovascular Imaging, ISSN 1936-878X, 2017, Volume 10, Issue 1, pp. 43 - 50
Abstract Objectives This study sought to assess the natural history and optimal timing of surgery in elderly patients with severe asymptomatic aortic stenosis...
Cardiovascular | aortic valve replacement | valvular heart disease | aortic stenosis | SURGERY | SURVIVAL | MODERATE | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK STRATIFICATION | SOCIETY | DATABASE | PREDICTORS | VALVE-REPLACEMENT | OUTCOMES | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Prospective Studies | Age Factors | Humans | Calcinosis - diagnostic imaging | Male | Aortic Valve - surgery | Asymptomatic Diseases | Calcinosis - surgery | Aortic Valve - pathology | Aortic Valve Stenosis - diagnostic imaging | Aortic Valve Stenosis - mortality | Mobility Limitation | Time Factors | Echocardiography, Doppler | Aged, 80 and over | Female | Aortic Valve Stenosis - surgery | Severity of Illness Index | Aortic Valve - diagnostic imaging | Comorbidity | Risk Factors | Aortic Valve Stenosis - physiopathology | Calcinosis - mortality | Kaplan-Meier Estimate | Proportional Hazards Models | Aortic Valve - physiopathology | Heart Valve Prosthesis Implantation - mortality | Treatment Outcome | Disease Progression | Disease-Free Survival | Heart Valve Prosthesis Implantation - adverse effects | Aged | Hemodynamics | Calcinosis - physiopathology | Care and treatment | Usage | Aortic valve stenosis | Heart valve replacement | Aged patients | Research | Health aspects
Cardiovascular | aortic valve replacement | valvular heart disease | aortic stenosis | SURGERY | SURVIVAL | MODERATE | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK STRATIFICATION | SOCIETY | DATABASE | PREDICTORS | VALVE-REPLACEMENT | OUTCOMES | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Prospective Studies | Age Factors | Humans | Calcinosis - diagnostic imaging | Male | Aortic Valve - surgery | Asymptomatic Diseases | Calcinosis - surgery | Aortic Valve - pathology | Aortic Valve Stenosis - diagnostic imaging | Aortic Valve Stenosis - mortality | Mobility Limitation | Time Factors | Echocardiography, Doppler | Aged, 80 and over | Female | Aortic Valve Stenosis - surgery | Severity of Illness Index | Aortic Valve - diagnostic imaging | Comorbidity | Risk Factors | Aortic Valve Stenosis - physiopathology | Calcinosis - mortality | Kaplan-Meier Estimate | Proportional Hazards Models | Aortic Valve - physiopathology | Heart Valve Prosthesis Implantation - mortality | Treatment Outcome | Disease Progression | Disease-Free Survival | Heart Valve Prosthesis Implantation - adverse effects | Aged | Hemodynamics | Calcinosis - physiopathology | Care and treatment | Usage | Aortic valve stenosis | Heart valve replacement | Aged patients | Research | Health aspects
Journal Article
Canadian Journal of Cardiology, ISSN 0828-282X, 2014, Volume 30, Issue 9, pp. 1027 - 1034
Abstract The optimal timing of valve surgery remains controversial. Biomarkers can be serially monitored and are objective laboratory measurements. Plasma...
Cardiovascular | LOW-FLOW | PROSPECTIVE VALIDATION | CARDIAC & CARDIOVASCULAR SYSTEMS | SEVERE AORTIC-STENOSIS | MYOCARDIAL FIBROSIS | PLASMA-LEVELS | VALVE-REPLACEMENT | MITRAL REGURGITATION | ASYMPTOMATIC PATIENTS | PROGNOSTIC VALUE | LEFT-VENTRICULAR FUNCTION | Heart Valve Diseases - blood | Heart Valve Diseases - physiopathology | Age Factors | Mitral Valve Insufficiency - surgery | Humans | Aortic Valve Insufficiency - physiopathology | Aortic Valve Stenosis - blood | Male | Tricuspid Valve Insufficiency - blood | Biomarkers - blood | Hypertension, Pulmonary - blood | Mitral Valve Stenosis - physiopathology | Aortic Valve Stenosis - mortality | Aortic Valve Insufficiency - blood | Tricuspid Valve Insufficiency - physiopathology | Sex Factors | Heart Valve Diseases - mortality | Female | Aortic Valve Stenosis - surgery | Mitral Valve Insufficiency - blood | Natriuretic Peptide, Brain - blood
Cardiovascular | LOW-FLOW | PROSPECTIVE VALIDATION | CARDIAC & CARDIOVASCULAR SYSTEMS | SEVERE AORTIC-STENOSIS | MYOCARDIAL FIBROSIS | PLASMA-LEVELS | VALVE-REPLACEMENT | MITRAL REGURGITATION | ASYMPTOMATIC PATIENTS | PROGNOSTIC VALUE | LEFT-VENTRICULAR FUNCTION | Heart Valve Diseases - blood | Heart Valve Diseases - physiopathology | Age Factors | Mitral Valve Insufficiency - surgery | Humans | Aortic Valve Insufficiency - physiopathology | Aortic Valve Stenosis - blood | Male | Tricuspid Valve Insufficiency - blood | Biomarkers - blood | Hypertension, Pulmonary - blood | Mitral Valve Stenosis - physiopathology | Aortic Valve Stenosis - mortality | Aortic Valve Insufficiency - blood | Tricuspid Valve Insufficiency - physiopathology | Sex Factors | Heart Valve Diseases - mortality | Female | Aortic Valve Stenosis - surgery | Mitral Valve Insufficiency - blood | Natriuretic Peptide, Brain - blood
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2015, Volume 116, Issue 6, pp. 913 - 918
Mitral regurgitation (MR) is common in ischemic heart disease and contributes to symptoms and mortality. This report compares the results of baseline...
Cardiovascular | SURVIVAL | IN-VITRO | CARDIAC & CARDIOVASCULAR SYSTEMS | VENA CONTRACTA AREA | QUANTIFICATION | MAGNETIC-RESONANCE | 3-DIMENSIONAL ECHOCARDIOGRAPHY | DILATED CARDIOMYOPATHY | DYSFUNCTION | 3D ECHOCARDIOGRAPHY | INSIGHTS | Severity of Illness Index | Cardiomyopathies - diagnostic imaging | Echocardiography | Echocardiography, Transesophageal | Humans | Middle Aged | Organ Size | Male | Mitral Valve - diagnostic imaging | Myocardial Ischemia - complications | Statistics, Nonparametric | Mitral Valve Insufficiency - complications | Myocardial Ischemia - diagnostic imaging | Cardiomyopathies - complications | Female | Aged | Mitral Valve Insufficiency - diagnostic imaging | Medical colleges | Ischemia | Surgery | Mortality | Clinical trials | Mitral valve insufficiency | Comparative analysis | Heart diseases | Studies | Heart rate | Heart failure | Heart attacks | Laboratories | Cardiomyopathy | Blood pressure | Kidney diseases | Cardiology | Mitral Regurgitation | Heart Failure
Cardiovascular | SURVIVAL | IN-VITRO | CARDIAC & CARDIOVASCULAR SYSTEMS | VENA CONTRACTA AREA | QUANTIFICATION | MAGNETIC-RESONANCE | 3-DIMENSIONAL ECHOCARDIOGRAPHY | DILATED CARDIOMYOPATHY | DYSFUNCTION | 3D ECHOCARDIOGRAPHY | INSIGHTS | Severity of Illness Index | Cardiomyopathies - diagnostic imaging | Echocardiography | Echocardiography, Transesophageal | Humans | Middle Aged | Organ Size | Male | Mitral Valve - diagnostic imaging | Myocardial Ischemia - complications | Statistics, Nonparametric | Mitral Valve Insufficiency - complications | Myocardial Ischemia - diagnostic imaging | Cardiomyopathies - complications | Female | Aged | Mitral Valve Insufficiency - diagnostic imaging | Medical colleges | Ischemia | Surgery | Mortality | Clinical trials | Mitral valve insufficiency | Comparative analysis | Heart diseases | Studies | Heart rate | Heart failure | Heart attacks | Laboratories | Cardiomyopathy | Blood pressure | Kidney diseases | Cardiology | Mitral Regurgitation | Heart Failure
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2013, Volume 112, Issue 11, pp. 1812 - 1818
The mechanisms underlying functional mitral regurgitation (MR) and the relation between mechanism and severity of MR have not been evaluated in a large,...
Cardiovascular | SURVIVAL | CARDIAC & CARDIOVASCULAR SYSTEMS | LEFT-VENTRICULAR DYSFUNCTION | RECOMMENDATIONS | BYPASS SURGERY | RECONSTRUCTION | 3-DIMENSIONAL ECHOCARDIOGRAPHY | DILATED CARDIOMYOPATHY | DOPPLER | SEVERITY | INSIGHTS | Severity of Illness Index | Multivariate Analysis | Cardiomyopathies - diagnostic imaging | Echocardiography, Transesophageal | Prospective Studies | Humans | Middle Aged | Echocardiography, Three-Dimensional | Male | Cardiomyopathies - etiology | Stroke Volume | Mitral Valve - diagnostic imaging | Myocardial Ischemia - complications | Myocardial Ischemia - diagnostic imaging | Female | Aged | Mitral Valve Insufficiency - diagnostic imaging | Mitral Valve Insufficiency - etiology | Heart failure | Clinical trials | Care and treatment | Echocardiography | Ischemia | Surgery | Variables | Ultrasonic imaging | Software | Cardiology | Mortality | Methods | heart failure | mitral regurgitation | ischemic cardiomyopathy
Cardiovascular | SURVIVAL | CARDIAC & CARDIOVASCULAR SYSTEMS | LEFT-VENTRICULAR DYSFUNCTION | RECOMMENDATIONS | BYPASS SURGERY | RECONSTRUCTION | 3-DIMENSIONAL ECHOCARDIOGRAPHY | DILATED CARDIOMYOPATHY | DOPPLER | SEVERITY | INSIGHTS | Severity of Illness Index | Multivariate Analysis | Cardiomyopathies - diagnostic imaging | Echocardiography, Transesophageal | Prospective Studies | Humans | Middle Aged | Echocardiography, Three-Dimensional | Male | Cardiomyopathies - etiology | Stroke Volume | Mitral Valve - diagnostic imaging | Myocardial Ischemia - complications | Myocardial Ischemia - diagnostic imaging | Female | Aged | Mitral Valve Insufficiency - diagnostic imaging | Mitral Valve Insufficiency - etiology | Heart failure | Clinical trials | Care and treatment | Echocardiography | Ischemia | Surgery | Variables | Ultrasonic imaging | Software | Cardiology | Mortality | Methods | heart failure | mitral regurgitation | ischemic cardiomyopathy
Journal Article
JACC: Cardiovascular Imaging, ISSN 1936-878X, 2010, Volume 3, Issue 12, pp. 1287 - 1295
Pulmonary hypertension is defined as an increase in mean pulmonary arterial pressure ≥25 mm Hg at rest and occurs in a majority of patients with heart failure....
Cardiovascular | pulmonary vascular resistance | right ventricle | perfusion scintigraphy | pulmonary hypertension | CHRONIC HEART-FAILURE | CARDIAC & CARDIOVASCULAR SYSTEMS | VENOOCCLUSIVE DISEASE | CARDIAC MAGNETIC-RESONANCE | VENTILATION-PERFUSION SCINTIGRAPHY | CAPILLARY HEMANGIOMATOSIS | HIGH-RESOLUTION CT | DIASTOLIC DYSFUNCTION | ARTERIAL-HYPERTENSION | VASCULAR-RESISTANCE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | DOPPLER-ECHOCARDIOGRAPHY | Diagnostic Imaging - methods | Predictive Value of Tests | Hypertension, Pulmonary - diagnosis | Prognosis | Humans | Hypertension, Pulmonary - physiopathology | Hemodynamics | Ventricular Function, Right | Practice Guidelines as Topic
Cardiovascular | pulmonary vascular resistance | right ventricle | perfusion scintigraphy | pulmonary hypertension | CHRONIC HEART-FAILURE | CARDIAC & CARDIOVASCULAR SYSTEMS | VENOOCCLUSIVE DISEASE | CARDIAC MAGNETIC-RESONANCE | VENTILATION-PERFUSION SCINTIGRAPHY | CAPILLARY HEMANGIOMATOSIS | HIGH-RESOLUTION CT | DIASTOLIC DYSFUNCTION | ARTERIAL-HYPERTENSION | VASCULAR-RESISTANCE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | DOPPLER-ECHOCARDIOGRAPHY | Diagnostic Imaging - methods | Predictive Value of Tests | Hypertension, Pulmonary - diagnosis | Prognosis | Humans | Hypertension, Pulmonary - physiopathology | Hemodynamics | Ventricular Function, Right | Practice Guidelines as Topic
Journal Article
Journal of Clinical Lipidology, ISSN 1933-2874, 2015, Volume 9, Issue 4, pp. 533 - 541
Background Lipoprotein(a) (Lp(a)) is a proatherogenic plasma lipoprotein currently established as an independent risk factor for the development of...
Cardiovascular | Lipoprotein(a) | Oxidized phospholipids | Coronary artery disease | Monocyte subsets | Atherosclerosis | MYOCARDIAL-INFARCTION | PERIPHERAL-BLOOD | HIGH-DENSITY-LIPOPROTEIN | LP(A) LIPOPROTEIN | HEART-DISEASE | INFLAMMATION | ANGINA-PECTORIS | CARDIOVASCULAR-DISEASE | PHARMACOLOGY & PHARMACY | CORONARY-ARTERY-DISEASE | Atherosclerosis - pathology | Receptors, IgG - blood | Oxidation-Reduction | Humans | Middle Aged | Risk Factors | Apolipoprotein B-100 - blood | Male | Monocytes - metabolism | Coronary Artery Disease - blood | Lipopolysaccharide Receptors - blood | Atherosclerosis - blood | Cell Lineage | Coronary Artery Disease - pathology | Monocytes - pathology | Female | GPI-Linked Proteins - blood | Phospholipids - blood | Aged | Lipoprotein(a) - blood | Original
Cardiovascular | Lipoprotein(a) | Oxidized phospholipids | Coronary artery disease | Monocyte subsets | Atherosclerosis | MYOCARDIAL-INFARCTION | PERIPHERAL-BLOOD | HIGH-DENSITY-LIPOPROTEIN | LP(A) LIPOPROTEIN | HEART-DISEASE | INFLAMMATION | ANGINA-PECTORIS | CARDIOVASCULAR-DISEASE | PHARMACOLOGY & PHARMACY | CORONARY-ARTERY-DISEASE | Atherosclerosis - pathology | Receptors, IgG - blood | Oxidation-Reduction | Humans | Middle Aged | Risk Factors | Apolipoprotein B-100 - blood | Male | Monocytes - metabolism | Coronary Artery Disease - blood | Lipopolysaccharide Receptors - blood | Atherosclerosis - blood | Cell Lineage | Coronary Artery Disease - pathology | Monocytes - pathology | Female | GPI-Linked Proteins - blood | Phospholipids - blood | Aged | Lipoprotein(a) - blood | Original
Journal Article
Journal of Clinical Lipidology, ISSN 1933-2874, 2015, Volume 9, Issue 6, pp. 801 - 806.e1
Background Remnant cholesterol has been defined as the cholesterol present in triglyceride-rich remnant lipoproteins. Elevated levels of remnant cholesterol...
Cardiovascular | Remnant cholesterol | Premature myocardial infarction | Lipids | LIPOPROTEIN | LDL-CHOLESTEROL | TRIGLYCERIDES | PHARMACOLOGY & PHARMACY | ISCHEMIC-HEART-DISEASE | CORONARY-ARTERY-DISEASE | Myocardial Infarction - blood | Cholesterol - blood | Humans | Risk Factors | Adult | Female | Male | Biomarkers - blood | Lipoproteins - blood
Cardiovascular | Remnant cholesterol | Premature myocardial infarction | Lipids | LIPOPROTEIN | LDL-CHOLESTEROL | TRIGLYCERIDES | PHARMACOLOGY & PHARMACY | ISCHEMIC-HEART-DISEASE | CORONARY-ARTERY-DISEASE | Myocardial Infarction - blood | Cholesterol - blood | Humans | Risk Factors | Adult | Female | Male | Biomarkers - blood | Lipoproteins - blood
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2012, Volume 110, Issue 11, pp. 1699 - 1703
Anemia is associated with the cardiovascular outcome in healthy subjects but its impact on outcome in patients with cardiovascular disease has not yet been...
Cardiovascular | HEART | CARDIAC & CARDIOVASCULAR SYSTEMS | DISEASE | ATHEROSCLEROSIS | RISK | ANEMIA | ARTERY | Predictive Value of Tests | Prognosis | Survival Rate - trends | Follow-Up Studies | Humans | Middle Aged | Austria - epidemiology | Hemoglobins - metabolism | Male | Biomarkers - blood | Time Factors | Carotid Stenosis - mortality | Cause of Death - trends | Female | Aged | Retrospective Studies | Carotid Stenosis - diagnostic imaging | Carotid Stenosis - blood | Ultrasonography, Doppler, Duplex - methods | Heart attacks | Sensitivity analysis | Mortality | Cardiovascular disease | Regression analysis | Family medical history | Confidence intervals | Survival analysis | Ultrasonic imaging | Older people | Coronary vessels | Atherosclerosis | Kidney diseases | Chronic illnesses
Cardiovascular | HEART | CARDIAC & CARDIOVASCULAR SYSTEMS | DISEASE | ATHEROSCLEROSIS | RISK | ANEMIA | ARTERY | Predictive Value of Tests | Prognosis | Survival Rate - trends | Follow-Up Studies | Humans | Middle Aged | Austria - epidemiology | Hemoglobins - metabolism | Male | Biomarkers - blood | Time Factors | Carotid Stenosis - mortality | Cause of Death - trends | Female | Aged | Retrospective Studies | Carotid Stenosis - diagnostic imaging | Carotid Stenosis - blood | Ultrasonography, Doppler, Duplex - methods | Heart attacks | Sensitivity analysis | Mortality | Cardiovascular disease | Regression analysis | Family medical history | Confidence intervals | Survival analysis | Ultrasonic imaging | Older people | Coronary vessels | Atherosclerosis | Kidney diseases | Chronic illnesses
Journal Article
American Heart Journal, ISSN 0002-8703, 2007, Volume 153, Issue 2, pp. 289 - 295
Background The aim of our prospective multicenter Clopidogrel Registry was to evaluate the efficacy and safety of a 300-mg loading dose of clopidogrel at the...
Cardiovascular | 600-MG | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | TASK-FORCE | REDUCTION | PLATELET INHIBITION | RANDOMIZED-TRIAL | ST-SEGMENT ELEVATION | INTERVENTION | ASPIRIN | ANTIPLATELET THERAPY | Coronary Artery Disease - surgery | Prospective Studies | Drug Administration Schedule | Humans | Middle Aged | Male | Treatment Outcome | Combined Modality Therapy | Coronary Artery Disease - drug therapy | Preoperative Care | Ticlopidine - analogs & derivatives | Myocardial Revascularization | Time Factors | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - administration & dosage | Female | Registries | Stents | Clopidogrel | Dosage and administration | Research | Drug therapy | Coronary heart disease | Patient outcomes | Stent (Surgery) | Emergency medical care | Heart attacks | Coronary vessels
Cardiovascular | 600-MG | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | TASK-FORCE | REDUCTION | PLATELET INHIBITION | RANDOMIZED-TRIAL | ST-SEGMENT ELEVATION | INTERVENTION | ASPIRIN | ANTIPLATELET THERAPY | Coronary Artery Disease - surgery | Prospective Studies | Drug Administration Schedule | Humans | Middle Aged | Male | Treatment Outcome | Combined Modality Therapy | Coronary Artery Disease - drug therapy | Preoperative Care | Ticlopidine - analogs & derivatives | Myocardial Revascularization | Time Factors | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - administration & dosage | Female | Registries | Stents | Clopidogrel | Dosage and administration | Research | Drug therapy | Coronary heart disease | Patient outcomes | Stent (Surgery) | Emergency medical care | Heart attacks | Coronary vessels
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2010, Volume 3, Issue 1, pp. 90 - 97
Objectives Our aim was to test whether serum levels of matrix metalloproteinase (MMP)-2 and -9 are associated with the development of in-stent restenosis (ISR)...
Cardiovascular | metalloproteinases | restenosis | drug-eluting stents | angioplasty | ARTERIAL INJURY | STABLE ANGINA | CARDIAC & CARDIOVASCULAR SYSTEMS | PROLIFERATION | MUSCLE-CELL-MIGRATION | PACLITAXEL | IN-VITRO | BALLOON INJURY | MATRIX-METALLOPROTEINASE-9 | INHIBITOR | EXPRESSION | Up-Regulation | Cardiovascular Agents - administration & dosage | Drug-Eluting Stents | Angioplasty, Balloon, Coronary - instrumentation | Prospective Studies | Risk Assessment | Humans | Risk Factors | Logistic Models | Treatment Outcome | Coronary Artery Disease - enzymology | Coronary Restenosis - diagnostic imaging | Angioplasty, Balloon, Coronary - adverse effects | Coronary Angiography | Matrix Metalloproteinase 2 - blood | Sirolimus - administration & dosage | Coronary Artery Disease - diagnostic imaging | Coronary Artery Disease - therapy | Time Factors | Odds Ratio | Paclitaxel - administration & dosage | Coronary Restenosis - enzymology | Coronary Restenosis - etiology | Matrix Metalloproteinase 9 - blood
Cardiovascular | metalloproteinases | restenosis | drug-eluting stents | angioplasty | ARTERIAL INJURY | STABLE ANGINA | CARDIAC & CARDIOVASCULAR SYSTEMS | PROLIFERATION | MUSCLE-CELL-MIGRATION | PACLITAXEL | IN-VITRO | BALLOON INJURY | MATRIX-METALLOPROTEINASE-9 | INHIBITOR | EXPRESSION | Up-Regulation | Cardiovascular Agents - administration & dosage | Drug-Eluting Stents | Angioplasty, Balloon, Coronary - instrumentation | Prospective Studies | Risk Assessment | Humans | Risk Factors | Logistic Models | Treatment Outcome | Coronary Artery Disease - enzymology | Coronary Restenosis - diagnostic imaging | Angioplasty, Balloon, Coronary - adverse effects | Coronary Angiography | Matrix Metalloproteinase 2 - blood | Sirolimus - administration & dosage | Coronary Artery Disease - diagnostic imaging | Coronary Artery Disease - therapy | Time Factors | Odds Ratio | Paclitaxel - administration & dosage | Coronary Restenosis - enzymology | Coronary Restenosis - etiology | Matrix Metalloproteinase 9 - blood
Journal Article
American Heart Journal, ISSN 0002-8703, 2007, Volume 153, Issue 2, pp. 212.e1 - 212.e7
Background Previous data suggest that bone marrow–derived stem cells (BM-SCs) decrease the infarct size and beneficially affect the postinfarction remodeling....
Cardiovascular | HEART | ENDOTHELIAL PROGENITOR CELLS | CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | CLINICAL-TRIAL | REGENERATION ENHANCEMENT | ISCHEMIC MYOCARDIUM | PERFUSION | NEOVASCULARIZATION | TOPCARE-AMI | SKELETAL MYOBLAST TRANSPLANTATION | Myocardial Infarction - surgery | Single-Blind Method | Multicenter Studies as Topic | Prospective Studies | Time Factors | Humans | Myocardium | Bone Marrow Transplantation - methods | Research Design | Coronary Vessels | Cardiac patients | Heart attack | Stem cells | Studies | Bone marrow | Heart attacks | Transplants & implants
Cardiovascular | HEART | ENDOTHELIAL PROGENITOR CELLS | CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | CLINICAL-TRIAL | REGENERATION ENHANCEMENT | ISCHEMIC MYOCARDIUM | PERFUSION | NEOVASCULARIZATION | TOPCARE-AMI | SKELETAL MYOBLAST TRANSPLANTATION | Myocardial Infarction - surgery | Single-Blind Method | Multicenter Studies as Topic | Prospective Studies | Time Factors | Humans | Myocardium | Bone Marrow Transplantation - methods | Research Design | Coronary Vessels | Cardiac patients | Heart attack | Stem cells | Studies | Bone marrow | Heart attacks | Transplants & implants
Journal Article
JACC: Cardiovascular Imaging, ISSN 1936-878X, 2014, Volume 7, Issue 9, pp. 956 - 958